The rand was firmer on Tuesday as investor risk appetite was boosted by the outcome of the EU leaders summit and positive Covid-19 vaccine news.

Pfizer and BioNTech announced positive results from their vaccine trial in Germany, which added to the promising results reported earlier this month, giving hope that a vaccine might be available soon.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now